Published in Medical Letter on the CDC and FDA, July 31st, 2005
Study 1: Scientists have analyzed gamma/delta T-lymphocyte activity against Mycobacterium bovis.
According to a study from the United States, "Gamma/delta T lymphocytes contain the unique capability of responding to pathogens in both an inmate and acquired immune response. Previously, gamma delta lymphocytes have been reported to respond to Mycobacterium tuberculosis determined by proliferation and IFN-gamma production. Unlike alpha/beta lymphocytes, gamma/delta lymphocytes constitutively express a natural killer receptor providing gamma/delta lymphocytes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA